From Suspicion to Diagnosis: Analysis on the Clinical Characteristics of 37 Cases of IgG4-Related Disease (IgG4-RD) in Northeast China

References

• Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015;385(9976):1460–1471. doi:10.1016/S0140-6736(14)60720-0
   PubMed Web of Science ®Google Scholar
• Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol. 2012;22(1):1–14. doi:10.3109/s10165-011-0508-6
   PubMed Web of Science ®Google Scholar
• Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22(1):21–30. doi:10.3109/s10165-011-0571-z
   PubMed Web of Science ®Google Scholar
• Wallace ZS, Naden RP, Chari S, et al. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020;79(1):77–87. doi:10.1136/annrheumdis-2019-216561
   PubMed Web of Science ®Google Scholar
• Lanzillotta M, Campochiaro C, Mancuso G, et al. Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes. Rheumatology. 2020;59(9):2435–2442. doi:10.1093/rheumatology/keaa221
   PubMed Web of Science ®Google Scholar
• Wallace ZS, Zhang Y, Perugino CA, et al. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis. 2019;78:406–412. doi:10.1136/annrheumdis-2018-214603
   PubMed Web of Science ®Google Scholar
• Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine. 2015;94(15):e680. doi:10.1097/MD.0000000000000680
   PubMed Web of Science ®Google Scholar
• Kamisawa T, Okamoto A, Funata N. Clinicopathological features of autoimmune pancreatitis in relation to elevation of serum IgG4. Pancreas. 2005;31(1):28–31. doi:10.1097/01.mpa.0000167000.11889.3a
   PubMed Web of Science ®Google Scholar
• Liu Y, Xue M, Wang Z, et al. Salivary gland involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 428 patients. Rheumatology. 2020;59:634–640. doi:10.1093/rheumatology/kez280
   PubMed Web of Science ®Google Scholar
• Wallace ZS, Zhang Y, Perugino CA, Naden R, Choi HK. Stone JHACR/ EULAR IgG4-RD Classification Criteria Committee. Clinical phenotypes of IgG4-related disease: an analysis of two international crosssectional cohorts. Ann Rheum Dis. 2019;78:406–412.
   PubMed Web of Science ®Google Scholar
• Culver EL, Sadler R, Bateman AC, et al. Increases in IgE, Eosinophils, and Mast Cells Can be Used in Diagnosis and to Predict Relapse of IgG4-Related Disease. Clin Gastroenterol Hepatol. 2017;15:1444–1452. doi:10.1016/j.cgh.2017.02.007
   PubMed Web of Science ®Google Scholar
• Wallace ZS, Mattoo H, Mahajan VS, et al. Predictors of disease relapse in IgG4-related disease following rituximab[Oxford]. Rheumatology. 2016;55:1000–1008. doi:10.1093/rheumatology/kev438
   PubMed Web of Science ®Google Scholar
• Kamisawa T, Anjiki H, Egawa N, Kubota N. Allergic manifestations in autoimmune pancreatitis. Eur J Gastroenterol Hepatol. 2009;21(10):1136–1139. doi:10.1097/MEG.0b013e3283297417
   PubMed Web of Science ®Google Scholar
• Della Torre E, Mattoo H, Mahajan VS, Carruthers M, Pillai S, Stone JH. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy. 2014;69(2):269–272. doi:10.1111/all.12320
   PubMed Web of Science ®Google Scholar
• Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-Related Disease: clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis Rheumatol. 2015;67(9):2466–2475. doi:10.1002/art.39205
   PubMed Web of Science ®Google Scholar
• Sato Y, Kojima M, Takata K, et al. Multicentric Castleman’s disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases. J Clin Pathol. 2010;63(12):1084–1089. doi:10.1136/jcp.2010.082958
   PubMed Web of Science ®Google Scholar
• Hara S, Kawano M, Mizushima I, et al. A condition closely mimicking IgG4-related disease despite the absence of serum IgG4 elevation and IgG4-positive plasma cell infiltration. Mod Rheumatol. 2016;26(5):784–789. doi:10.3109/14397595.2014.916836
   PubMed Web of Science ®Google Scholar
• Doorenspleet ME, Hubers LM, Culver EL, et al. Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary/pancreatic malignancies. Hepatology. 2016;64:501–507. doi:10.1002/hep.28568
   PubMed Web of Science ®Google Scholar
• Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015;74(1):14–18. doi:10.1136/annrheumdis-2013-204907
   PubMed Web of Science ®Google Scholar
• Fonti R, Conson M, Del Vecchio S. PET/CT in radiation oncology. Semin Oncol. 2019;46(3):202–209. doi:10.1053/j.seminoncol.2019.07.001
   PubMed Web of Science ®Google Scholar
• Haroon A, Zumla A, Bomanji J. Role of fluorine 18 fluorodeoxyglucose positron emission tomography-computed tomography in focal and generalized infectious and inflammatory disorders. Clin Infect Dis. 2012;54(9):1333–1341. doi:10.1093/cid/cis193
   PubMed Web of Science ®Google Scholar
• Yao Y, Ou X. [The application of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in inflammation and infectious disease]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2020;37(4):730–735. Chinese. doi:10.7507/1001-5515.202002030
   PubMedGoogle Scholar
• Zhang J, Chen H, Ma Y, et al. Characterizing IgG4-related disease with 18F-FDG PET/CT: a prospective cohort study. Eur J Nucl Med Mol Imaging. 2014;41(8):1624–1634. doi:10.1007/s00259-014-2729-3
   PubMed Web of Science ®Google Scholar
• Pan Q, Luo Y, Zhang W. Recurrent Immunoglobulin G4-Related Disease Shown on 18F-FDG and 68Ga-FAPI PET/CT. Clin Nucl Med. 2020;45(4):312–313. doi:10.1097/RLU.0000000000002919
   PubMed Web of Science ®Google Scholar
• Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366(6):539–551. doi:10.1056/NEJMra1104650
   PubMed Web of Science ®Google Scholar
• Lanzillotta M, Mancuso G, Della-Torre E. Advances in the diagnosis and management of IgG4 related disease. BMJ. 2020;16(369):m1067. doi:10.1136/bmj.m1067
   Web of Science ®Google Scholar
• Khosroshahi A, Wallace ZS, Crowe JL, et al. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis Rheumatol. 2015;67(7):1688–1699. doi:10.1002/art.39132
   PubMed Web of Science ®Google Scholar
• Ramadass T, Balaji V, Sheba SKJ, Vali Ahmed KS, Abdurahiman R. IgG4-Related Disease (IgG4-RD) Presenting as a Mass in the Carotid Triangle Masquerading Paraganglioma. Indian J Otolaryngol Head Neck Surg. 2017;69(2):259–262. doi:10.1007/s12070-016-0976-2
   PubMed Web of Science ®Google Scholar
• Sarkar A, Pitchumoni CS. The protean manifestations of IgG4-RD in gastrointestinal disorders. Dis Mon. 2015;61(12):493–515. doi:10.1016/j.disamonth.2015.09.008
   PubMed Web of Science ®Google Scholar
• Ebbo M, Grados A, Samson M, et al. Long-term efficacy and safety of rituximab in IgG4-related disease: data from a French nationwide study of thirty-three patients. PLoS One. 2017;12(9):e0183844. doi:10.1371/journal.pone.0183844
   PubMed Web of Science ®Google Scholar